Continuing Education - Goals and Prerequisite Skills and Knowledge

• Continuing Education Information
• Course Evaluation

The goal of the conference is to bring together public health professionals to encourage the exchange of scientific and public health information on global emerging infectious disease issues. The conference will provide important new information regarding emerging infectious diseases to public health professionals.

1. Exchange scientific information on emerging and re-emerging infectious disease issues in the United States and other countries.
2. Exchange scientific information on vaccine preventable diseases and their relationship to emerging and re-emerging infectious diseases in the United States and other countries.
3. Exchange scientific information on animal disease issues and their relationship to emerging and re-emerging infectious diseases in the United States and other countries
4. Exchange scientific information on chronic disease issues and their relationship to emerging and re-emerging infectious diseases in the United States and other countries
5. Exchange scientific information on opportunistic disease issues and their relationship to emerging and re-emerging infectious diseases in the United States and other countries.
6. Discuss programs and activities that have been implemented to address emerging and re-emerging infectious disease threats.
7. Identify program gaps with respect to emerging and re-emerging infectious diseases.
8. Increase awareness in the public health and scientific communities of issues related to emerging and re-emerging infectious diseases.
9. Encourage and enhance partnerships to address emerging and re-emerging infectious diseases.

Prerequisite Skills and Knowledge

Participants should have a medical/science background. Participants may be researchers, clinicians, epidemiologists, laboratorians, veterinarians, nurses, or other health professionals.

Disclosure Statements

All faculty members participating in continuing medical education programs sponsored by CDC are expected to disclose any real or perceived conflict of interest related to the content of their presentation, as well as any off-label uses of a product or drug. A listing of faculty disclosures will be available in the program addendum.

• Elizabeth Barnett, MD would like to disclose that she receives honoraria as a member of the Speakers’ Bureau for Merck.
• Maria Brandl, PhD would like to disclose that she performs contracted research as a researcher for DSM Foods, Inc.
• Lin Chen, MD would like to disclose that she receives an honorarium as the Associate Editor for the Travel Medicine Advisor.
• Tai-Ho Chen, MD would like to disclose that his spouse receives a salary for employment by Maxim Healthcare Services.
• Sarah Cleaveland, PhD would like to disclose that she receives an honorarium and lecture fee as a speaker for Intervet.
• Nancy Cox, PhD would like to disclose that she receives an honorarium as the Outstanding Federal Government Employee of the Year from the Partnership for Public Service.
• Ron Dagan, MD would like to disclose that he receives honorariums & grants as a speaker and consultant and for research from Wyeth and GSK. He also would like to disclose that he receives grants for research from Medimmune and MSD as well as an honorarium as a speaker and consultant for Novartis.
• David Fredricks, MD would like to disclose that he receives a consulting fee for consulting for Oxonica, Inc.
• Joel Gaydos, MD would like to disclose that his spouse receives an honorarium and grant support as an investigator for Becton Dickson and laboratory kits as an investigator for GenProbe. He would also like to disclose that his spouse receives honorariums as an Advisory Committee member from both Genocea and Trinity Unigold.
• Gregory Gray, MD, MPH would like to disclose that he receives research contracts as a principal investigator for GlxoSmithKline Biologicals, ThermoFisher/Remel, Quidel, Inc., and ViroStat, Inc.
• Sharon Hillier, PhD would like to disclose that she receives honorariums as a consultant for Ther-Rx Corportation, Enzybiolics, and Tibotec/J&J.
• Jay Keystone, MD, MSc would like to disclose that he receives honorariums as a speaker from GlaxoSmithKline, Sanofi Pasteur, and Merck Frosst.
• Jeffrey Klausner, MD, MPH would like to disclose that he receives an educator grant for an educational program from King Pharmaceutical.
• Keith Klugman, PhD would like to disclose that he receives honorariums as a consultant/speaker from Wyeth, GSK, and Bayer.
• Ian Lipkin, MD would like to disclose that he receives stock options as a member of the Scientific Advisory Board for 454 Life Sciences and Tetragenetics.
• Roger Mahr, DVM would like to disclose that he receives dividends as a stockholder from Monsanto Co. and Pfizer Inc.
• Christian Massire, PhD would like to disclose that he receives salary as an employee of Ibis BioSciences, Inc.
• Mark Miller, MD would like to disclose that his spouse receives a consulting fee as a consultant for Roche and Merck.
• Thomas Monath, MD would like to disclose that he receives consulting fees for consultaion on smallpox vaccine from Acambis.
• Janet Nicholson, PhD would like to disclose that she receives book royalties from Wiley-Liss Publishing.
• Walter Orenstein, MD would like to disclose his relationship in studies with Novartis on influenza vaccine coverage in health care, with Merck on HIV vaccine studies (Hope Clinic MUMPS research study; Uganda MVNA Immunization Project), with sanofi pastier on Yellow Fever Vaccine and IG –Hope Clinic, with Encorium, DSMB on VEE, Plague, and other potential BT vaccines, and with GSK, DSMB on pneumococcal vaccine development. He would also like to disclose that he receives honorariums as a member of the Board of Directors for the Sabin Vaccine Institute, Every Child by Two, and the National Foundation for Infectious Diseases. He would like to disclose his relationship as a member of 317 Coalition for Vaccine Finance, present Advocates for immunization funding at CDC.
• David Relman, MD would like to disclose that he receives consultant fees as a member of the Scientific Advisory Board for NanBio, Cepheid, Novartis, and Applied BioSystems. He would also like to disclose that he receives an honorarium as a course lecturer from Bristol-Myers Squibb.
• Louis Rice, MD would like to disclose that he receives honorariums as a consultant for Wyeth, Cadence, Novexel, Johnson & Johnson, Advanced Life Sciences, and Pfizer. He would like to disclose that he receives honorariums as a speaker from Arpida and Targanta. He would also like to disclose that he receives an honorarium as a member of the Data Safety Monitoring Board for Paratek.
• Lynette Sawyer, DPH would like to disclose that she receives a salary as an employee of Cerus Corporation.
• Sam Telford, MS, ScD would like to disclose that he receives honorariums as a consulting scientific expert for Imugen, Inc. and Fuller Laboratories.
• James Versalovic, MD, PhD would like to disclose that he receives an honorarium as an advisor for Roche Diagnostics.
• Patricia Walker, MD, DTM&H would like to disclose that she receives royalties as a co-editor for Immigrant Medicine textbook from Elsevier Publishing.
• Angela Weaver, MPH would like to disclose that she receives a salary from the Public Health Institute, employment (contracted to USAID).
• Samuel Yang, MD would like to disclose that he receives a royalty for patent licensing from Cambrex.

Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of the presentation on Major Global Disease Initiatives: Malaria, Tuberculosis, HIV-AIDS. Regina Rabinovich, MD, MPH will present the research and development pipeline for products for these diseases.

Program Info  |  Meeting Info  |  Registration & Housing  |   Exhibits  |  Partners   |  Contact  |  Sitemap
Managed by The American Society for Microbiology,  1752 N Street NW,  Washington, D.C.  20036